Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: William Hayden who wrote (2921)	2/12/1999 12:59:00 PM
From: angra manyu	Read Replies (1) \| Respond to of 3725

William, Y'day in the "All Things Considered" segment of the NPR news, one of the feature stories was about Ultrafast CT scan. It did not mention the company by name, but did refer to the Fed financed study which will use the Imatron machine. The report was neutral. Mr. Grant, one of the Veeps, had a couple of sentences in the piece. All in all IMAT is getting a steady stream of press, but the company is not getting the message out sufficiently. The only answer to the problem is when the insurance companies start covering the expenses. Right now it is around $450 a pop. Some of the doctors interviewed were against the idea of a person going for a scan without a specific recommendation by a doctor. Krishna